Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The aim of this study was to assess the therapeutic potential of active immunisation with GnRH-glycys-PPD in a hormone-dependent experimental model. Mammary tumours were induced in female rats using dimethylbenzanthracene (DMBA) and the effects of GnRH immunoneutralisation on tumour development were evaluated. High titres of anti-GnRH IgG correlated with a decrease in oestrogen levels and subsequent tumour suppression. A comparison of immunised and non-immunised animals showed that when GnRH-specific IgG levels were at a maximum titre (80-100 micrograms/ml), nearly 10% of the GnRH-glycys-PPD treated animals showed mammary masses, compared with all the non-treated animals at the same stage in the study. When the antibody levels fell, tumour regrowth was observed, but to a level below that observed in the non-treated animals. Following further treatment with the analogue, the tumours regressed again, showing their retention of hormone dependency. This is consistent with other endocrine manipulations in the treatment of breast cancer; the advantages of immunisation with GnRH-glycys lies in its non-toxicity and reduction in side-effects, which were mainly adjuvant-induced.

LanguageEnglish
Pages1468-1478
Number of pages11
JournalEuropean Journal of Cancer
Volume33
Issue number9
DOIs
Publication statusPublished - 31 Aug 1997

Fingerprint

Gonadotropin-Releasing Hormone
Estrogens
Breast Neoplasms
Tuberculin
Neoplasms
Therapeutics
Hormones
Immunization
Vaccination
Breast
Theoretical Models
Immunoglobulin G
Antibodies

Keywords

  • antibodies
  • antineoplastic
  • experimental mammary neoplasms
  • gonad atrophy
  • gonadotrophin releasing hormone analogue
  • hormone-dependent
  • immunotherapy
  • serum oestrogen

Cite this

@article{b21bd61e5dd94f628e8a8614dcf95881,
title = "Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer",
abstract = "The aim of this study was to assess the therapeutic potential of active immunisation with GnRH-glycys-PPD in a hormone-dependent experimental model. Mammary tumours were induced in female rats using dimethylbenzanthracene (DMBA) and the effects of GnRH immunoneutralisation on tumour development were evaluated. High titres of anti-GnRH IgG correlated with a decrease in oestrogen levels and subsequent tumour suppression. A comparison of immunised and non-immunised animals showed that when GnRH-specific IgG levels were at a maximum titre (80-100 micrograms/ml), nearly 10{\%} of the GnRH-glycys-PPD treated animals showed mammary masses, compared with all the non-treated animals at the same stage in the study. When the antibody levels fell, tumour regrowth was observed, but to a level below that observed in the non-treated animals. Following further treatment with the analogue, the tumours regressed again, showing their retention of hormone dependency. This is consistent with other endocrine manipulations in the treatment of breast cancer; the advantages of immunisation with GnRH-glycys lies in its non-toxicity and reduction in side-effects, which were mainly adjuvant-induced.",
keywords = "antibodies, antineoplastic, experimental mammary neoplasms, gonad atrophy, gonadotrophin releasing hormone analogue, hormone-dependent, immunotherapy, serum oestrogen",
author = "Ferro, {V. A.} and Stimson, {W. H.}",
year = "1997",
month = "8",
day = "31",
doi = "10.1016/S0959-8049(97)00126-3",
language = "English",
volume = "33",
pages = "1468--1478",
journal = "European Journal of Cancer",
issn = "0959-8049",
number = "9",

}

TY - JOUR

T1 - Immunoneutralisation of gonadotrophin releasing hormone

T2 - European Journal of Cancer

AU - Ferro, V. A.

AU - Stimson, W. H.

PY - 1997/8/31

Y1 - 1997/8/31

N2 - The aim of this study was to assess the therapeutic potential of active immunisation with GnRH-glycys-PPD in a hormone-dependent experimental model. Mammary tumours were induced in female rats using dimethylbenzanthracene (DMBA) and the effects of GnRH immunoneutralisation on tumour development were evaluated. High titres of anti-GnRH IgG correlated with a decrease in oestrogen levels and subsequent tumour suppression. A comparison of immunised and non-immunised animals showed that when GnRH-specific IgG levels were at a maximum titre (80-100 micrograms/ml), nearly 10% of the GnRH-glycys-PPD treated animals showed mammary masses, compared with all the non-treated animals at the same stage in the study. When the antibody levels fell, tumour regrowth was observed, but to a level below that observed in the non-treated animals. Following further treatment with the analogue, the tumours regressed again, showing their retention of hormone dependency. This is consistent with other endocrine manipulations in the treatment of breast cancer; the advantages of immunisation with GnRH-glycys lies in its non-toxicity and reduction in side-effects, which were mainly adjuvant-induced.

AB - The aim of this study was to assess the therapeutic potential of active immunisation with GnRH-glycys-PPD in a hormone-dependent experimental model. Mammary tumours were induced in female rats using dimethylbenzanthracene (DMBA) and the effects of GnRH immunoneutralisation on tumour development were evaluated. High titres of anti-GnRH IgG correlated with a decrease in oestrogen levels and subsequent tumour suppression. A comparison of immunised and non-immunised animals showed that when GnRH-specific IgG levels were at a maximum titre (80-100 micrograms/ml), nearly 10% of the GnRH-glycys-PPD treated animals showed mammary masses, compared with all the non-treated animals at the same stage in the study. When the antibody levels fell, tumour regrowth was observed, but to a level below that observed in the non-treated animals. Following further treatment with the analogue, the tumours regressed again, showing their retention of hormone dependency. This is consistent with other endocrine manipulations in the treatment of breast cancer; the advantages of immunisation with GnRH-glycys lies in its non-toxicity and reduction in side-effects, which were mainly adjuvant-induced.

KW - antibodies

KW - antineoplastic

KW - experimental mammary neoplasms

KW - gonad atrophy

KW - gonadotrophin releasing hormone analogue

KW - hormone-dependent

KW - immunotherapy

KW - serum oestrogen

UR - http://www.sciencedirect.com/science/journal/09598049

U2 - 10.1016/S0959-8049(97)00126-3

DO - 10.1016/S0959-8049(97)00126-3

M3 - Article

VL - 33

SP - 1468

EP - 1478

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 9

ER -